Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Jun 07, 2021 8:22am
286 Views
Post# 33338930

Holding Pattern

Holding Pattern

Not unexpectedly all analyses point to a holding pattern for THRM. Morningstar's Fair Value sp is at $.36 while thev1-star speculative valuation on impending solid news is $.84. The resistance levels and support are all between $.345 and $.37. News by the end of the week should demonstrate that there is still a significant need for testing.

A representative from WHO, interviewed this weekend on the CBC, still paints a dismal picture for the developing world when it comes to both infection rates and the rate of vaccinating their citizens. She pointed specifically to the whole of the African continent as well as countries in South America like Columbia and Brazil ....the connection to THRM and AcuVid which, of course, should not be understated.

Should be an interesting and exciting week.

GLTE!!!

<< Previous
Bullboard Posts
Next >>